Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,219 public trials 1,011 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Not Yet Recruiting

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

NCT07035860

Conditions: Bronchial Neoplasms, Carbon Ion Radiotheray, Carcinoma, Bronchogenic, +8 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Enteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung Cancer

NCT07035444

Conditions: Body Weight, Body Weight Changes, Bronchial Neoplasms, +15 more
Locations: Daping Hospital and the Research Institute of Surgery of The Third Military Medical University Chongqing, China

View Trial Details

Not Yet Recruiting

A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

NCT07031154

Conditions: Adebrelimab, Apatinib, Bronchial Neoplasms, +10 more
Locations: First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Not Yet Recruiting

PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy

NCT07014215

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer

NCT07004712

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Peking university cancer hospital Beijing, Haidian, China

View Trial Details

Not Yet Recruiting

Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC

NCT06998719

Conditions: Borderline Resectable Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Radiation-induced Toxicity of the Heart

NCT06986291

Conditions: Breast Cancer Female, Breast Diseases, Breast Neoplasms, +30 more
Locations: University of Technology, University Hospital Carl Gustav Carus, Department of Radiation Therapy and Radiation Oncology Dresden, Germany

View Trial Details

Not Yet Recruiting

High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

NCT06971406

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC

NCT06966583

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

NCT06963502

Conditions: Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations: The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, China

Sun Yat-sen University Cancer Center Shanghai, China

View Trial Details

Lung Neoplasms

Lung Neoplasms trial results

Related conditions